newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update

TORRANCE, Calif., Aug. 15, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported financial results for the three and six months ended